Shanghai Fosun Pharmaceutical Group Co Ltd (600196) - Total Liabilities

Latest as of March 2026: CN¥59.30 Billion CNY ≈ $8.68 Billion USD

Based on the latest financial reports, Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has total liabilities worth CN¥59.30 Billion CNY (≈ $8.68 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shanghai Fosun Pharmaceutical Group Co Ltd - Total Liabilities Trend (1995–2025)

This chart illustrates how Shanghai Fosun Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 600196 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Shanghai Fosun Pharmaceutical Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Fosun Pharmaceutical Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Giant Network Group Co Ltd SHE:002558	China	CN¥2.98 Billion
HELLENIC TELEC.ORG.ADR1/2 F:OTES	Germany	€2.93 Billion
Beijer Ref AB (publ) ST:BEIJ-B	Sweden	Skr23.89 Billion
Do-Fluoride Chemicals Co Ltd SHE:002407	China	CN¥13.48 Billion
GPT Group AU:GPT	Australia	AU$6.30 Billion
NINGBO SHANSHAN GDR/A F:OJ8	Germany	€22.34 Billion
NIBE Industrier AB (publ) ST:NIBE-B	Sweden	Skr34.77 Billion
Madison Air Solutions Corporation NYSE:MAIR	USA	$7.28 Billion

Liability Composition Analysis (1995–2025)

This chart breaks down Shanghai Fosun Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Fosun Pharmaceutical Group Co L market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Fosun Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Fosun Pharmaceutical Group Co Ltd (1995–2025)

The table below shows the annual total liabilities of Shanghai Fosun Pharmaceutical Group Co Ltd from 1995 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥57.97 Billion ≈ $8.48 Billion	+0.78%
2024-12-31	CN¥57.53 Billion ≈ $8.42 Billion	+1.18%
2023-12-31	CN¥56.85 Billion ≈ $8.32 Billion	+7.16%
2022-12-31	CN¥53.05 Billion ≈ $7.76 Billion	+18.11%
2021-12-31	CN¥44.92 Billion ≈ $6.57 Billion	+19.14%
2020-12-31	CN¥37.70 Billion ≈ $5.52 Billion	+2.13%
2019-12-31	CN¥36.92 Billion ≈ $5.40 Billion	-0.12%
2018-12-31	CN¥36.96 Billion ≈ $5.41 Billion	+14.67%
2017-12-31	CN¥32.23 Billion ≈ $4.72 Billion	+74.05%
2016-12-31	CN¥18.52 Billion ≈ $2.71 Billion	+5.62%
2015-12-31	CN¥17.53 Billion ≈ $2.57 Billion	+8.00%
2014-12-31	CN¥16.23 Billion ≈ $2.38 Billion	+37.45%
2013-12-31	CN¥11.81 Billion ≈ $1.73 Billion	+15.76%
2012-12-31	CN¥10.20 Billion ≈ $1.49 Billion	-6.57%
2011-12-31	CN¥10.92 Billion ≈ $1.60 Billion	+47.03%
2010-12-31	CN¥7.43 Billion ≈ $1.09 Billion	+62.33%
2009-12-31	CN¥4.58 Billion ≈ $669.48 Million	+47.92%
2008-12-31	CN¥3.09 Billion ≈ $452.60 Million	-0.82%
2007-12-31	CN¥3.12 Billion ≈ $456.35 Million	+4.46%
2006-12-31	CN¥2.99 Billion ≈ $436.85 Million	+6.86%
2005-12-31	CN¥2.79 Billion ≈ $408.80 Million	+18.54%
2004-12-31	CN¥2.36 Billion ≈ $344.86 Million	+7.03%
2003-12-31	CN¥2.20 Billion ≈ $322.21 Million	+50.18%
2002-12-31	CN¥1.47 Billion ≈ $214.55 Million	+65.73%
2001-12-31	CN¥884.68 Million ≈ $129.46 Million	+150.90%
2000-12-31	CN¥352.61 Million ≈ $51.60 Million	+75.30%
1999-12-31	CN¥201.15 Million ≈ $29.43 Million	+72.86%
1998-12-31	CN¥116.36 Million ≈ $17.03 Million	-24.66%
1997-12-31	CN¥154.46 Million ≈ $22.60 Million	+94.74%
1996-12-31	CN¥79.32 Million ≈ $11.61 Million	-2.20%
1995-12-31	CN¥81.10 Million ≈ $11.87 Million	--

About Shanghai Fosun Pharmaceutical Group Co Ltd

SHG:600196 China Drug Manufacturers - Specialty & Generic

Market Cap

$6.75 Billion

CN¥46.16 Billion CNY

Market Cap Rank

#2972 Global

#394 in China

Share Price

CN¥21.79

Change (1 day)

+0.97%

52-Week Range

CN¥21.58 - CN¥32.15

All Time High

CN¥85.06